Immunotherapy with FBTA05 (Bi20), a trifunctional bispecific anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion (DLI) in relapsed or refractory B-cell lymphoma after allogeneic stem cell transplantation: study protocol of an investigator-dr (Q36985497)
Jump to navigation
Jump to search
scientific article published on 02 July 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Immunotherapy with FBTA05 (Bi20), a trifunctional bispecific anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion (DLI) in relapsed or refractory B-cell lymphoma after allogeneic stem cell transplantation: study protocol of an investigator-dr |
scientific article published on 02 July 2013 |
Statements
1 reference
Immunotherapy with FBTA05 (Bi20), a trifunctional bispecific anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion (DLI) in relapsed or refractory B-cell lymphoma after allogeneic stem cell transplantation: study protocol of an investigator-dr (English)
1 reference
Raymund Buhmann
1 reference
Stanglmaier Michael
1 reference
Hess Juergen
1 reference
Lindhofer Horst
1 reference
Christian Peschel
1 reference
Hans-Jochem Kolb
1 reference
2 July 2013
1 reference
1 reference
2 July 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference